ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 166,65
0,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioDelivery Sciences International Inc (BDSI)

  7. BioDelivery Sciences International Inc (BDSI) Actualités

BDSI

BioDelivery Sciences (BDSI)

BioDelivery Sciences International Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BDSI
DateHeureSourceTitreSymboleSociété
10/02/202322h16Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BDSIBioDelivery Sciences International Inc
24/03/202211h01Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202222h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202222h10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202222h02Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:BDSIBioDelivery Sciences International Inc
22/03/202222h01GlobeNewswire Inc.Collegium Completes the Acquisition of BDSINASDAQ:BDSIBioDelivery Sciences International Inc
21/03/202212h08Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:BDSIBioDelivery Sciences International Inc
21/03/202212h02Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:BDSIBioDelivery Sciences International Inc
24/02/202218h07Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:BDSIBioDelivery Sciences International Inc
24/02/202217h07Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BDSIBioDelivery Sciences International Inc
18/02/202223h20Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:BDSIBioDelivery Sciences International Inc
18/02/202222h54Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:BDSIBioDelivery Sciences International Inc
15/02/202222h57Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:BDSIBioDelivery Sciences International Inc
15/02/202222h55Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BDSIBioDelivery Sciences International Inc
14/02/202213h45Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:BDSIBioDelivery Sciences International Inc
03/11/202121h19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BDSIBioDelivery Sciences International Inc
16/08/202114h00GlobeNewswire Inc.AzurRx BioPharma Announces Appointment of Terry Coelho to its Board of DirectorsNASDAQ:BDSIBioDelivery Sciences International Inc
11/03/202112h10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BDSIBioDelivery Sciences International Inc
15/07/202022h56Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BDSIBioDelivery Sciences International Inc
01/06/202023h24Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BDSIBioDelivery Sciences International Inc
11/05/202014h30GlobeNewswire Inc.BioDelivery Sciences Appoints Jeff Bailey Interim CEONASDAQ:BDSIBioDelivery Sciences International Inc
07/05/202022h01GlobeNewswire Inc.BioDelivery Sciences Reports Strong Q1 2020 ResultsNASDAQ:BDSIBioDelivery Sciences International Inc
28/04/202014h00GlobeNewswire Inc.BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020NASDAQ:BDSIBioDelivery Sciences International Inc
17/03/202021h25Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BDSIBioDelivery Sciences International Inc
12/03/202021h01GlobeNewswire Inc.BioDelivery Sciences Reports Strong Fourth Quarter and Full-Year 2019 ResultsNASDAQ:BDSIBioDelivery Sciences International Inc
09/03/202013h00GlobeNewswire Inc.BioDelivery Sciences Appoints Jeffrey A. Bailey to its Board of DirectorsNASDAQ:BDSIBioDelivery Sciences International Inc
27/02/202023h15GlobeNewswire Inc.BioDelivery Sciences Announces Phase I Clinical Trial Results at the American Academy of Pain Medicine’s 36th Annual Meetin...NASDAQ:BDSIBioDelivery Sciences International Inc
20/02/202014h00GlobeNewswire Inc.BioDelivery Sciences to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020NASDAQ:BDSIBioDelivery Sciences International Inc
13/01/202014h30GlobeNewswire Inc.BDSI Expects Fourth Quarter and 2019 Total Net Sales at the High End of Guidance: Reports Significantly Expanded Insurance Ac...NASDAQ:BDSIBioDelivery Sciences International Inc
06/01/202014h30GlobeNewswire Inc.BioDelivery Sciences Appoints Kevin Ostrander as Senior Vice President of Business DevelopmentNASDAQ:BDSIBioDelivery Sciences International Inc
 Showing the most relevant articles for your search:NASDAQ:BDSI

Dernières Valeurs Consultées

GATE
CAKEETH
PancakeSwap Token
LSE
TLAA
BIT
I09282
Intesa Sanpaolo
EU
VDPAU
Ville de Paris VPARIS3.2...
COIN
COLAAKRW
Cola Token
BIT
UC4PYV
Unicredit Bank
ASX
KLL
Kalium Lakes
COIN
DAIBTC
Dai Stablecoin
HITB
CROUSD
LSE
76QP
Municplty 39
TSX
VET
Vermilion Energy
LSE
QU98
Mor.st.fin 26
USOTC
CPPMF
Coppernico Metals (CE)
AQSE
VOY
Voyager Life
LSE
XD11
X Sustainable
BOV
K1SG34
Keysight Technologies
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés